Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
《临床与转化肿瘤学》是一本致力于促进实验肿瘤学与临床肿瘤学之间相互作用的国际期刊。它涵盖了癌症研究的各个方面，从处理肿瘤细胞的细胞和分子生物学的更基本的发现，到传统药物和新药的最先进的临床分析。此外，该杂志还致力于促进知识从基础实验室向临床实践的转移，出版教育系列，致力于缩小分子和临床肿瘤学家之间差距。肿瘤的分子生物学、癌症治疗新靶点的确定以及癌症研究和治疗的新技术是教育系列的主要主题。将考虑发表关于广泛主题的完整研究文章，包括疾病的分子和细胞基础、病因学、病理生理学、病理学、流行病学、临床特征以及癌症的诊断、预后和治疗。
Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02109-8
Multiple sclerosis outcomes after cancer immunotherapy
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02060-8
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02134-7
Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02182-z
Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02227-3
Coping strategies and depressive symptoms in cancer patients
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02123-w
Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02149-0
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02213-9
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02145-4
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02211-x
The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02142-7
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02183-y
Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02162-3
Prognostic value of thrombocytosis in patients undergoing surgery for colorectal cancer with synchronous liver metastases
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02093-z
Comparison of efficacy of HCAG and FLAG re-induction chemotherapy in acute myeloid leukemia patients of low- and intermediate-risk groups
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02085-z
The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02065-3
Improving the quality of care in the molecular era for children and adolescents with medulloblastoma
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02101-2
Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02048-4
Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02049-3
Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02215-7
Cost-effectiveness analysis of capecitabine plus bevacizumab versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer from Chinese societal perspective
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02114-x
Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02234-4
Current management of breakthrough cancer pain according to physicians from pain units in Spain
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02044-8
Dual-targeted therapeutic strategy combining CSC–DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02242-4
Altered expression and functional role of ion channels in leukemia: bench to bedside
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02147-2
Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02135-6
Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02141-8
The impact of PTEN deletion and ERG rearrangement on recurrence after treatment for prostate cancer: a systematic review and meta-analysis
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02170-3
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy?
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02084-0
Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+\u20094/CD44+\u2009prostate cancer stem cells
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02229-1
Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02097-9
Prognostic factors and survival in Ewing’s sarcoma treated by limb salvage surgery
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02067-1
Circulating tumor cells in the clinical cancer diagnosis
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02139-2
Is it time to change follow-up recommendations in colorectal cancer?
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02117-8
Assessment of the effect of the Aquamantys® system on local recurrence after hepatectomy for hepatocellular carcinoma through propensity score matching
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02092-0
Ethical commitment of Spanish oncologists to patients with prostate cancer: reflections on the statements of the new ASTRO/AUA guideline (2019 guideline amendment)
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02200-0
Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02247-z
Interplay between neural stem cells and glioblastoma: possible role of neurotrophin signaling
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02206-8
A new and simple scoring system to predict overall survival after irradiation for metastatic spinal cord compression
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02144-5
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02143-6
Comment on “Prognostic factors and survival in Ewing’s sarcoma treated by limb salvage surgery”
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02212-w
Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02047-5
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02079-x
Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02235-3
ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells)
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02091-1
Positive nonsentinel lymph nodes are associated with poor survival in breast cancer: results from a retrospective study
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-018-02031-5
Treatment of radiation-induced myelopathy with bevacizumab
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02209-5
A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02199-4
A new therapeutic approach in very refractory diffuse large B-cell lymphoma
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02172-1
Correction to: Recommendations for follow‑up of colorectal cancer survivors
来源期刊：Clinical and Translational OncologyDOI：10.1007/s12094-019-02088-w
